Error loading player: No playable sources found
SOP2401
Estate Planning for the 99%: Tax and Financial Planning Strategies When Estate Taxes Don't Matter
Date
November 11, 2024
$49
Standard Price
This product is also available as part of the following products:
This includes sessions from the conference: 2024 AICPA & CIMA National Tax Conference
An exploration of the many issues clients face in estate planning when estate taxes don’t really come into play because of the high estate tax exemption amounts. The tax and financial planning topics to be covered include the importance of lifetime documents such as health care proxies and powers of attorney, properly drafted wills, protecting inheritances with trusts, probate avoidance and beneficiary designation planning, long term care planning, and basis step up planning.
Learning Objectives
- Identify the non-estate tax planning aspects of an estate planning engagement, including necessary lifetime and testamentary documents, and the importance of proper beneficiary designations.
- Analyze the various income tax and financial matters relevant to a client's estate plan including asset protection planning, probate avoidance techniques, income tax basis step-up strategies, and long-term care planning opportunities.
Speaker
Partner, Rowlands, LeBrou & Griesmer, PLLC
Session Categories
Related Products
Trust Is Like The Air We Breathe
Trusts are an important tool for estate planning. They can expedite the distribution of assets, maintain privacy, and provide greater control and flexibility over how your assets are managed…
IRS Audit Hot Topics: Trends in Tax Enforcement
If you've read any of the IRS's press releases over the past two years, you should already be familiar with the IRS's top 3 enforcement targets: high net worth individuals, complex partnerships, and large corporations…
TCJA Expiring Provisions Planning
A number of significant provisions are set to expire after 2025…
R & D Update: IRC Section 174 Developments and Regulations
Starting with years beginning on or after January 1, 2022, the treatment of research and experimental expenditures has changed drastically from prior years…
